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United Kingdom the affinity and kinetics of very weak protein-protein
³Sir William Dunn School of Pathology interactions, provided that certain pitfalls are avoided
University of Oxford (van der Merwe and Barclay, 1994; Davis et al., 1998b).
Oxford, OX1 3RE Optimal SPR analysis requires immobilization of one
United Kingdom of the interacting molecules onto a sensor surface in
a consistent orientation without affecting its binding
properties. This was achieved by immobilizing HLA-A2
molecules that had been selectively biotinylated onSummary
b2-microglobulin onto streptavidin-coated surfaces. Solu-
ble CD8aa, which binds to HLA-A2 with a 1:1 stoichiom-The T cell surface glycoprotein CD8 enhances T cell
etry (Gao et al., 1997), eluted at the expected positionantigen recognition by binding to MHC class I mole-
(Mr z28000, calculated Mr 26826) when run at high con-cules. We show that human CD8aa binds to the MHC
centrations (z300 mM) on a gel-filtration column (Figureclass I molecule HLA-A2 with an extremely low affinity
1A), indicating that it does not form higher-order aggre-(Kd z0.2 mM at 378C) and with kinetics that are be-
gates and is therefore suitable for affinity and kinetictween 2 and 3 orders of magnitude faster than reported
analysis. This CD8aa produced a larger response whenfor T cell receptor/peptide-MHC interactions. Further-
injected over a surface presenting immobilized HLA-A2more, CD8aa had no detectable effect on a T cell
than when injected over a control surface, indicatingreceptor (TCR) binding to the same peptide-MHC class
binding (Figure 1B). A CD8aa variant with mutations inI complex. These binding properties provide an expla-
the CDR-2-like loop (Q54E/N55D), which contacts thenation as to why the CD8/MHC class I interaction is
a3 domain of HLA-A2 (Giblin et al., 1994; Gao et al.,unable to initiate cell-cell adhesion and how it can
1997), did not bind HLA-A2 (Figure 1B), confirming theenhance TCR recognition without interfering with its
specificity of this interaction.specificity.
The affinity of the CD8aa/HLA-A2 interaction was de-
termined by equilibrium binding analysis, as previously
described (van der Merwe et al., 1993, 1994, 1997). CD8aaIntroduction
was injected at a range of concentrations through flow
cells with either HLA-A2 or a control protein immobilizedCD8 and CD4 are T cell surface glycoproteins that en-
(Figure 2A). The binding at each concentration was ob-hance T cell antigen recognition by binding to major
tained by subtraction of the control response from thehistocompatibility complex (MHC) class I and II mole-
HLA-A2 response (Figure 2B). Both direct nonlinearcules, respectively, on antigen-presenting or target cells
curve fitting and Scatchard analysis gave a Kd of z150(Janeway, 1992; Zamoyska, 1994, 1998). Both CD8 and
mM at 258C (Figure 2B; Table 1). In order to address theCD4 are thought to bind to the same peptide-MHC mole-
possibility that biotinylation of b2-microglobulin, whichcules as the T cell receptor (TCR) and are thus commonly
makes some contacts with CD8aa (Gao et al., 1997;referred to as coreceptors (Janeway, 1992). While TCR/
Kern et al., 1998), changed the binding properties of thepeptide-MHC interactions have been extensively stud-
CD8aa/MHC class I interaction, the affinity was alsoied (Davis et al., 1998a), the interactions between core-
measured using HLA-A2 that had been enzymaticallyceptors and MHC molecules are less well characterized.
biotinylated at its carboxyl terminus (O'Callaghan et al.,CD8 exists on the cell surface as a homo (aa) or hetero
1999). CD8aa bound with a similar affinity to either form(ab) dimer (Zamoyska, 1994). Recently, crystal struc-
of HLA-A2 (Table 1), indicating that immobilization viatures have been obtained of complexes between soluble
biotinylated b2-microglobulin had little effect on thehuman and mouse CD8aa and the MHC class I mole-
CD8aa/MHC class I interaction. At 378C, the HLA-A2cules HLA-A2 and H-2Kb, respectively (Gao et al., 1997;
coupled via b2-microglobulin rapidly lost binding activ-Kern et al., 1998). In the present study, we use surface
ity, apparently as a result of dissociation of the heavy
chain from the sensor surface, leading to poor quality
data (Table 1). In contrast, HLA-A2 immobilized via bio-§ To whom correspondence should be addressed (e-mail: anton.
tinylated heavy chain was stable at 378C, enabling affin-vandermerwe@pathology.oxford.ac.uk).
‖ These authors contributed equally to this work. ity measurements to be performed (Figure 2C). CD8aa
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Figure 1. Specific Binding of CD8aa to
HLA-A2
(A) Gel-filtration of CD8aa. CD8aa (50 mL at
z300 mM) was separated on a Superdex
S-200 column. The elution positions of albu-
min (66 kDa), carbonic anhydrase (29 kDa),
and cytochrome c (12 kDa) are shown.
(B) CD8aa binds specifically to immobilized
HLA-A2. Similar concentrations (z300 mM) of
wild-type CD8aa or the CD8aa mutant Q54E/
N55D were injected (solid bars) for 90 s
through flow cells with HLA-A2 (solid trace)
or the control protein OX68 (dotted trace) im-
mobilized. HLA-A2 presented an influenza
matrix peptide (HLA-A2-flu, see Table 1) and
was coupled via biotinylated b2-microglob-
ulin. This experiment was performed at 258C using a flow rate of 5 ml 3 min21 with z1500 RU of HLA-A2 or the control protein OX68 immobilized.
The high background responses seen in the control flow-cell reflect the high refractive index of the injected CD8aa samples, a consequence
of very high protein concentrations.
bound HLA-A2-peptide complexes with a Kd of z200 from the flow cell (van der Merwe et al., 1994), the flow-
rate was increased to 1.67 ml 3 s21, the maximal ratemM at 378C (Figure 2C; Table 1). Similar affinities were
measured for CD8aa binding to several different pep- possible on the BIAcore2000. At this flow-rate, CD8aa
dissociated with an apparent koff of 18 s21. The rate attide/HLA-A2 complexes (Table 1).
which the background response falls in the control flow
cell (z24 s21) provides an estimate of the washing time.CD8aa Dissociates Rapidly from HLA-A2
Since preliminary analysis indicated that the kinetics This agrees well with the theoretical value (z28 s21)
calculated for this flow rate (flow rate 4 flow cell volumeof the CD8aa/MHC-peptide interactions are extremely
rapid, data were collected at 0.1 s intervals, the fastest [z0.06 mL]). The true koff for the CD8aa/MHC class I
interaction may well be greater than 18 s21 since werate possible on the BIAcore2000 (Figure 3A). When
CD8aa was injected over HLA-A2 at 258C, equilibrium could not exclude rebinding following dissociation, a
phenomenon commonly seen in BIAcore experimentswas reached within 0.4 s (Figure 3A), making direct de-
termination of the association rate constant (kon) impos- (van der Merwe et al., 1993, 1994, 1997). In addition, the
koff at 378C is likely to be higher than at 258C becausesible. Dissociation was also extremely fast, with the re-
sponse returning to baseline within 0.4 s of the end of the affinity is lower (Table 1). If the koff is taken to be $
18 s21 and the Kd z 126 mM (at 258C), the kon can bethe injection (Figure 3A). Because the dissociation time
was of the same order as the time taken to wash protein calculated to be $ 140000 M21 3 s21 (kon 5 koff/Kd). This
Figure 2. The Affinity of CD8aa Binding to
HLA-A2
(A) CD8aa was injected at the indicated con-
centrations for 30 s through flow cells with
z8000 RUs of either HLA-A2-flu (solid trace)
or the control protein OX68 (dotted trace) im-
mobilized. HLA-A2-flu was coupled via bio-
tinylated b2-microglobulin. The amount of
CD8aa that bound HLA-A2-flu at each con-
centration was calculated as the difference
between the responses at equilibrium in the
HLA-A2-flu and control flow cells and is plot-
ted in (B). (C) A similar experiment was per-
formed at 378C using HLA-A2-HY (z2400 RU)
coupled via biotinylated heavy chain and
OX68 (z4000 RU) as a control protein. In (B)
and (C) the solid lines in the main plots repre-
sent nonlinear fits of the Langmuir binding
isotherm to the data. These yielded Kd values
of 156 and 205 mM, respectively. The insets
show Scatchard transformations of the same
data; the Kd values shown were obtained
from the slopes by linear regression (Kd 5
21/slope). These experiments were per-
formed at a flow-rate of 10 ml 3 min21.
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unpublished data). This indicates that the discrepanciesTable 1. Summary of Affinity Constants
between our findings and those of Garcia et al. (1996)
Kd (mM)b are not the result of species differences. Neither are
Peptidea Immobilization 258C 378C the discrepancies the result of allelic differences, since
Garcia et al. (1996) obtained very similar results withFlu b2-microglobulin 159 6 18 (n 5 5) .207 (n 5 2)c
H-2K, H-2D, and H-2L alleles, and we have measuredPol b2-microglobulin 126 6 34 (n 5 7) .236 (n 5 1)c
similar affinities for CD8aa binding to several HLA-A,H-Y heavy chain 173 (n 5 1) 211 (n 5 1)
HA-1 heavy chain 107 6 2 (n 5 2) 132 6 10 (n 5 2) -B, and -C alleles (G. F. G. et al., unpublished data). A
third possibility is that the differences result from thea Flu, Influenza matrix protein 58-66 (GILGFVFTL); Pol, HIV-1 poly-
absence of the mucin-like stalk region from the form ofmerase 476-484 (ILKEPVHGV); H-Y, male-specific, minor histocom-
patibility antigen from the protein SMCY (FIDSYICQV); HA-1, minor CD8 used in this study. This seems unlikely, however,
histocompatibility antigen from one allele of the KIAA0223 gene because CD8 binds MHC class I in an orientation that
(VLHDDLLEA). makes it difficult to envisage a direct interaction be-
b Mean 6 SD or, for n 5 2, mean 6 range of n independent determina-
tween the stalk region and MHC class I (Gao et al.,tions.
1997; Kern et al., 1998). A fourth possibility is that thec Saturation was not achieved in these experiments. The values
discrepancy results from the presence of multivalentshown are the concentrations of CD8aa that gave 50% of the binding
obtained with the highest concentration of CD8aa. The actual Kd aggregates, a pitfall commonly encountered when using
values are likely to be higher than this. high protein concentrations in SPR experiments (van
der Merwe et al., 1993, 1994; Davis et al., 1998b). The
binding of aggregated material has certain characteris-
kon is no slower than measured for other protein-protein tic features (van der Merwe et al., 1993, 1994; Davis et
interactions (Mason and Williams, 1986; van der Merwe al., 1998b) that are consistent with the data presented
and Barclay, 1994; Davis et al., 1998b), indicating that by Garcia et al. (1996). First, the apparent koff is very
the low affinity of the CD8aa/MHC class I interaction is slow because binding is multivalent. Second, because
not a consequence of an unusually slow kon. multivalent aggregates are usually minor contaminants
(van der Merwe et al., 1993, 1994), their concentration
Comparison with the Mouse CD8aa/MHC is much lower (,5%) than the total concentration of
Class I Interaction the protein. Because the total concentration (C) is used
The affinity and kinetic values obtained in this study are when calculating the association rate constant (kon) from
very different to the values previously reported for the the association rate (kon 5 association rate/C), the calcu-
mouse CD8aa/MHC class I interaction. Garcia et al. lated apparent kon is much lower than the true kon. Finally,
(1996) reported an affinity z5-fold higher for the latter because of the mixture of monovalent and multivalent
interaction (Kd 30±39 mM at 258C). The most striking material, the association and dissociation phases will
difference, however, is in the binding kinetics. Garcia et exhibit both very fast and slow phases (see Figure 1A,
al. (1996) measured kon (z103 M21 3 s21) and koff (z0.05 Garcia et al. [1996]), with large differences in rate con-
s21) values between 2 and 3 orders of magnitude slower stants for each phase. While mass transport limitations
than the values obtained in the present study. In con- and rebinding can lead to biphasic binding kinetics
trast, we have recently found that soluble mouse MHC (Schuck, 1997), it is unlikely to result in phases with
class I binds a soluble, recombinant form of mouse such markedly different rate constants. Although Garcia
CD8aa with affinity and kinetic constants (Kd . 200 mM, analyzed their CD8 by gel-filtration, aggregates may
koff .10 s21) very similar to those reported here for the have been present at below detectable levels. We have
observed that very low levels of such aggregates (,2%)human CD8aa/MHC class I interaction (G. F. G. et al.,
Figure 3. The Kinetics of CD8aa Binding
HLA-A2
(A) CD8aa (23 mM) was injected (solid bar) at
0.83 mL 3 s21 (50 mL 3 min21) through a flow
cell with HLA-A2-flu (z6600 RUs) or a control
protein CAMPATH-1 (z3000 RUs) immobi-
lized to the sensor surface. Individual data
points are shown (circles).
(B) The dissociation phase is shown following
injection of CD8aa at 0.83 ml 3 s21 or 1.67
ml 3 s21 through flow cells with HLA-A2-flu
or CAMPATH-1 immobilized. HLA-A2-flu was
coupled via biotinylated b2-microglobulin.
The response in the control flow cell was sub-
tracted from the response in the HLA-A2-flu
flow cell. To aid comparison, the data are
normalized, with the response at the start of
the dissociation phase set at 100%. The lines
are first order exponential fits to the data and
give the apparent koff values shown. This ex-
periment was performed at 258C.
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Figure 4. The Effect of CD8aa Binding on a
Soluble TCR Binding to the Same HLA-A2-flu
Complex
(A) The indicated soluble TCR concentrations
were injected for 60 s with (filled circles)
or without (open circles) CD8aa (120 mM)
through flow cells with HLA-A2-flu (z4700
RUs) or a control protein CD5 (z4100 RUs)
immobilized. HLA-A2-flu was coupled via bio-
tinylated b2-microglobulin. Binding was cal-
culated as the difference between equilibrium
responses measured in the HLA-A2-flu and
control flow cells. The difference in the bind-
ing seen with or without CD8aa is also plotted
(squares) and ranges between 240±340 RUs.
In the absence of TCR binding (i.e., with injec-
tion over z4700 RUs of immobilized HLA-A2-
pol), the same concentration of CD8aa gives a binding response ([response in HLA-A2-pol flow cell]Ð[response in control flow cell]) of 306 6
30 RUs (triangles).
(B) Time-dependence of response following injection of soluble TCR (49 mM, open circles) alone or with CD8aa (120 mM, filled circles) through
a flow cell with HLA-A2-flu immobilized (z4700 RU). The background responses measured simultaneously in the control flow cell (z4100 RUs
of CD5 immobilized) have been subtracted. First order exponential decay curves (from t 5 63 s to t 5 100 s) fitted these data well (solid lines)
and gave identical koff values (0.08 6 0.005 s21). These experiments were performed at 258C at a flow-rate of 5 ml 3 min21.
can dominate the binding if the monomeric interaction of the peptide-MHC complex that binds TCR. Further-
more, if multivalent aggregates of CD8 are indeed pres-has a low affinity and high concentrations of the protein
are injected (van der Merwe et al., 1993, 1994; Davis et ent (see above), they may form multivalent peptide-
MHC/CD8 complexes with enhanced avidity for (andal., 1998b).
slow dissociation rates from) immobilized TCR. Another
possible explanation for the discrepancy between ourCD8aa and a TCR Bind Independently
to HLA-A2-flu results and those of Garcia et al. (1996) is that the mucin-
like stalk regions of CD8, which are absent from theWe next examined whether the binding of CD8aa to a
peptide-MHC class I complex influenced the binding of CD8 used in the present study, interact directly with the
TCR. However, unless the CD8 stalk displays remark-a T cell receptor (TCR) to the same peptide-MHC (Figure
4). In order to simplify interpretation of the experiment, able flexibility, the orientation of CD8 binding to MHC
class I would place it some distance from the TCR (Gaothis analysis was performed with peptide-MHC immobi-
lized and the TCR and CD8aa in solution. The affinity et al., 1997). Finally, we cannot exclude the possibility
that CD8 only stabilizes some TCR/peptide-MHC combi-of a soluble TCR specific for HLA-A2 presenting the
influenza matrix peptide (HLA-A2-flu, Table 1) was unaf- nations. However, if this is the case, our results imply
that the enhancing effect of CD8 on the TCR/peptide-fected by the presence of soluble CD8aa; the binding
of the TCR and CD8aa to HLA-A2-flu appeared to be MHC interaction reported by Garcia et al. (1996) is not
a general feature of CD8 function.simply additive (Figure 4A). Similarly, CD8aa binding
had no detectable effect on kinetics of the TCR/HLA-
A2-flu interaction (see Figure 4B, dissociation phase).
This lack of effect of CD8aa on the TCR/peptide-MHC Implications for CD8 Function
Our results indicate that CD8 binds MHC class I with aclass I interaction is consistent with structural data
showing that while the a3 domains of mouse and human lower affinity than measured between conventional cell-
cell recognition molecules (Table 2) (van der Merwe andMHC class I do move upon CD8aa binding, no dis-
cernable conformational changes are evident on the Barclay, 1994; Davis et al., 1998b). The latter tend to
have affinities with Kd values # 100 mM, suggesting thatTCR binding platform (Gao et al., 1997; Kern et al., 1998).
Our finding that CD8aa and TCR bind to peptide-MHC an affinity of Kd z 100 mM might be close to the lower
limit of what is needed for adhesion mediated by mole-class I independently in solution does not rule out the
possibility that CD8 will enhance TCR binding to pep- cules that interact with a 1:1 stoichiometry. In support
of this, a recent study of the rat CD2/CD48 interactiontide-MHC class I on cells. Clearly, indirect interactions
between CD8 and the TCR/CD3, mediated by shared (Dustin et al., 1997) suggests that its solution affinity
(3DKd 60±90 mM) results in a membrane-attached orassociations with signaling molecules (Thome et al.,
1996), would also enable CD8 to stabilize the TCR/pep- two-dimensional affinity (2DKd z 45 molecules/mm2)
that is just sufficient to drive adhesion at physiologicaltide-MHC interaction (see below).
Our results differ from Garcia et al. (1996), who re- surface densities of CD48 (z100 molecules/mm2). Per-
haps more striking than the low affinity of the CD8aa/ported that purified soluble CD8aa and CD8ab en-
hanced the binding of soluble peptide-MHC class I to MHC class I interaction are the extremely fast kinetics.
The koff ($ 18 s21) is considerably faster than the koffTCR immobilized onto a sensor surface. However, inter-
pretation of their experiment is complicated by the fact values reported for TCR/peptide-MHC interactions,
which range from 0.01 to 0.1 s21 at 258C for agonistthat SPR detects changes in mass and so CD8 will en-
hance the SPR response simply by increasing the mass peptides (Davis et al., 1998a). These differences have
TCR and CD8 Binding to MHC Class I
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Table 2. Affinity and Kinetic Constants for Molecular Interactions Involved in T Cell Antigen Recognitiona
kon koff Kdb
Interaction (M21 3 s21) (s21) (mM) References
CD8aa/HLA-A2 $100 000 $18 z200 this study
TCR/peptide-MHCc 600±22 000 0.01±0.1 1±90 (Davis et al., 1998a)
CD2/CD58 $400 000 $4 z16 (van der Merwe et al., 1994)
CD28/CD80 $660 000 $1.6 4 (van der Merwe et al., 1997)
L-selectin/GlyCAM-1 $100000 $10 z105 (Nicholson et al., 1998)
LFA-1/ICAM-1 Ð Ð z100 (Lollo et al., 1993)
a All interactions shown are between human molecules except for TCR/peptide-MHC interactions, which have only been studied with mouse
molecules. All measurements were performed at 378C except for TCR/peptide-MHC interactions, which were measured at 258C.
b Kd values shown were obtained by equilibrium binding but the range of Kd values shown for TCR interactions includes some that were
calculated from the koff and kon.
c The range of values reported for several non-alloreactive interactions are shown.
important implications for the mechanism of CD8 func- the CD4/MHC class II interaction that makes recruitment
necessary. More recent data (Hampl et al., 1997), whichtion (see below), since recent data (Alam et al., 1996;
Lyons et al., 1996) support models (McKeithan, 1995; show that CD4 enhances T cell hybridoma recognition
of agonist but not antagonist peptides, are consistentDavis and van der Merwe, 1996; Rabinowitz et al., 1996)
with this mode of coreceptor function if one postulatesof TCR triggering in which the koff of the TCR/peptide-
that TCR triggering with an antagonist peptide doesMHC interaction is a primary factor determining the out-
not lead to recruitment of coreceptor to the TCR/CD3come of TCR ligation.
complex.The very low solution affinity of the CD8/MHC class
In summary, the binding properties reported here forI interaction provides an explanation for its inability to
the CD8/MHC class I interaction support the suggestionindependently initiate cell-cell adhesion, except when
(Xu and Littman, 1993; Thome et al., 1996) that a func-these molecules are expressed at unphysiologically high
tionally significant CD8/peptide-MHC class I interactionsurface densities (Norment et al., 1988). Interestingly,
can only occur when CD8 is recruited into a TCR/CD3/CD8 is able to mediate adhesion to surface-immobilized
CD8 complex so that physically associated CD8 andMHC class I molecules, but only following tyrosine-
TCR/CD3 bind simultaneously to the same peptide-kinase-dependent signaling through the TCR (O'Rourke
MHC class I complex. We suggest that the distinct bind-et al., 1990; O'Rourke and Mescher, 1992). It is now
ing properties of the TCR and CD8 for peptide-MHCknown that this signaling leads to lck-mediated recruit-
class I are necessary to ensure that the specificity ofment of CD8 into tyrosine-phosphorylated TCR/CD3
this interaction is dominated by the TCR.complexes (Beyers et al., 1992; Thome et al., 1996). We
suggest that the affinity of CD8 for MHC class I is so
Experimental Procedureslow that significant engagement only occurs following
recruitment of CD8 into the TCR/CD3 complex. Impor-
Soluble CD8aa Preparation
tantly, this recruitment will follow initial, coreceptor- Purified soluble human CD8aa (residues 1±120) was expressed in
independent activation of the TCR/CD3 complex, as pre- Escherichia coli, refolded, and purified as described (Gao et al.,
1998). The extinction coefficient was determined by amino acidviously suggested (Thome et al., 1996). Once recruited,
analysis to be 32480 M21 3 cm21. DNA encoding the CD8aa mutantCD8 could enhance peptide-MHC ligation by adding to
Q54E/N55D was produced using the QuikChange Site-Directed Mu-the much stronger TCR/peptide-MHC interaction. We
tagenesis Kit (Stratagene) and checked by dideoxy DNA sequencing
suggest that peptide specificity is maintained because of the entire coding portion. The mutant protein was expressed and
the very low affinity and fast kinetics of the CD8/MHC refolded as for wild-type CD8aa and purified by gel filtration as an
class I interaction mean that TCR/CD3/CD8 complexes approximately 30 kDa homodimer. At least 90% of the purified wild-
type and mutant CD8aa could be immunoprecipitated by the MAbsbind only very transiently to nonspecific peptide-MHC
OKT8 and 51.1 (data not shown), both of which block MHC class Iclass I complexes. Only when TCR binds to specific
binding in adhesion assays (Norment et al., 1988), suggesting thatpeptide-MHC class I is the interaction between the TCR/
the bulk of these proteins were correctly folded and active. Thus, the
CD3/CD8 and peptide/MHC class I complexes suffi- CD8aa concentration was calculated from the extinction coefficient,
ciently stable for T cell receptor triggering. assuming 100% activity.
This mode of coreceptor function, in which the core-
Soluble HLA-A2 Preparationceptor first associates with a previously activated TCR/
HLA-A2 heavy chain was expressed in E. coli and refolded as pre-CD3 complex before engaging peptide-MHC, was first
viously described together with synthetic peptides (Genosys) and
proposed for CD4 (Xu and Littman, 1993) in order to biotinylated b2-microglobulin (Garboczi et al., 1992; Vessey et al.,
explain the results of experiments with CD4-lck chimeric 1997). Prior to refolding with HLA-A2, b2-microglobulin was chemi-
proteins. Xu and Littman's (1993) findings suggested cally biotinylated as described (Vessey et al., 1997) using N-hydroxy-
succinimido-biotin (Sigma). HLA-A2 that had been enzymaticallythat lck-mediated recruitment of CD4 into the TCR/CD3
biotinylated on the heavy chain C terminus was produced as de-complex is necessary in order for CD4 to enhance T cell
scribed (Altman et al., 1996; O'Callaghan et al., 1999).antigen recognition (Xu and Littman, 1993). However,
lck-mediated recruitment is not essential when CD4 is Soluble TCR Preparation
expressed at very high levels (Killeen and Littman, 1993), The TCR studied derives from the JM22 T cell clone (Moss et al.,
1991; Lehner et al., 1995). It is specific for an HLA-A2-restrictedconsistent with the notion that it is the low affinity of
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peptide (GILGFVFTL) from the influenza matrix protein (58±66) and E.A., and van der Merwe, P.A. (1997). Low affinity interaction of
human or rat T cell adhesion molecule CD2 with its ligand alignsutilizes gene segments TCRAV10S2J9S11C1 and TCRBV17S1J2
S7C2. Expression, refolding, and purification of a soluble form of adhering membranes to achieve high physiological affinity. J. Biol.
Chem. 272, 30889±30898.this TCR is to be described in detail elsewhere (B. E. W. et al.,
unpublished data). In brief, TCR a and b chains carrying c-Jun (a) Gao, G.F., Gerth, U.C., Wyer, J.R., Willcox, B.E., O'Callaghan, C.A.,
and c-Fos (b) heterodimerisation motifs at their carboxyl termini Zhang, Z., Jones, E.Y., Bell, J.I., and Jakobsen, B.K. (1998). Assem-
were expressed separately in E. coli, solubilized from inclusion bod- bly and crystallization of the complex between the human T cell
ies, and refolded together. The ab heterodimers were purified on a coreceptor CD8a homodimer and HLA-A2. Prot. Sci. 7, 1245±1249.
POROS 10 HQ column using a BioCAD/SPRINT Perfusion Chroma- Gao, G.F., Tormo, J., Gerth, U.C., Wyer, J.R., McMichael, A.J., Stuart,
tography system (Perseptive Biosystems Inc., Framingham, MA), D.I., Bell, J.I., Jones, E.Y., and Jakobsen, B.K. (1997). Crystal struc-
before analysis on the BIAcore. ture of the complex between human CD8aa and HLA-A2. Nature
At least 84% of the TCR could be precipitated by sepharose beads 387, 630±634.
coated with HLA-A2-flu (data not shown), indicating that the bulk
Garboczi, D.N., Hung, D.T., and Wiley, D.C. (1992). HLA-A2-peptideof the TCR was correctly folded. The TCR concentration was calcu-
complexes: refolding and crystallization of molecules expressed inlated from the extinction coefficient (105500 M21 3 cm21, deter-
Escherichia coli and complexed with single antigenic peptides.mined by amino acid analysis), assuming 100% activity.
Proc. Natl. Acad. Sci. USA 89, 3429±3433.
Garcia, K.C., Scott, C.A., Brunmark, A., Carbone, F.R., Peterson,Surface Plasmon Resonance
P.A., Wilson, I.A., and Teyton, L. (1996). CD8 enhances formationSPR studies were performed using a BIAcore 2000 (BIAcore AB, St
of stable T-cell receptor/MHC class I molecule complexes. NatureAlbans, UK) in HBS (BIAcore AB). HBS contains 10 mM HEPES (pH
384, 577±581.7.4), 150 mM NaCl, 3.4 mM EDTA, and 0.005% Surfactant P20.
Giblin, P.A., Leahy, D.J., Mennone, J., and Kavathas, P.B. (1994).Streptavidin (Sigma) was covalently coupled to Research Grade
The role of charge and multiple faces of the CD8 alpha/alpha homo-CM5 sensor chips (BIAcore) via primary amines using the Amine
dimer in binding to major histocompatibility complex class I mole-Coupling kit (BIAcore). For coupling, the streptavidin was dissolved
cules: support for a bivalent model. Proc. Natl. Acad. Sci. USA 91,in 10 mM sodium acetate (pH 5.5) and injected at 0.5 mg/ml. Immobi-
1716±1720.lization levels ranged from 6000 to 11000 Response Units. Biotinyl-
ated HLA-A2 and control proteins were then immobilized at the Hampl, J., Chien, Y.H., and Davis, M.M. (1997). CD4 augments the
indicated levels by injection at 0.05 to 0.15 mg/ml for 0.5 to 10 response of a T cell to agonist but not to antagonist ligands. Immu-
min over streptavidin-coupled surfaces. The biotinylated control nity 7, 379±385.
proteins used included mouse (OX68, IgG2a, anti-rat CD4) and rat Janeway, C.A. (1992). The T cell receptor as a signaling machine:
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